Assessment of drug disposition in the perfused rat brain by statistical moment analysis. 1991

T Sakane, and M Nakatsu, and A Yamamoto, and M Hashida, and H Sezaki, and S Yamashita, and T Nadai
Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan.

Drug disposition in the brain was investigated by statistical moment analysis using an improved in situ brain perfusion technique. The right cerebral hemisphere of the rat was perfused in situ. The drug and inulin were injected into the right internal carotid artery as a rapid bolus and the venous outflow curve at the posterior facial vein was obtained. The infusion rate was adjusted to minimize the flow of perfusion fluid into the left hemisphere. The obtained disposition parameters were characteristics and considered to reflect the physicochemical properties of each drug. Antipyrine showed a small degree of initial uptake. Therefore, its apparent distribution volume (Vi) and apparent intrinsic clearance (CLint,i) were small. Diazepam showed large degrees of both influx and efflux and, thus, a large Vi. Water showed parameters intermediate between those of antipyrine and those of diazepam. Imipramine, desipramine, and propranolol showed a large CLint,i compared with those of the other drugs. The extraction ratio of propranolol significantly decreased with increasing concentrations of unlabeled propranolol in the perfusion fluid. These findings may be explained partly by the tissue binding of these drugs. In conclusion, the present method is useful for studying drug disposition in the brain.

UI MeSH Term Description Entries
D008297 Male Males
D008432 Mathematical Computing Computer-assisted interpretation and analysis of various mathematical functions related to a particular problem. Statistical Computing,Computing, Statistical,Mathematic Computing,Statistical Programs, Computer Based,Computing, Mathematic,Computing, Mathematical,Computings, Mathematic,Computings, Mathematical,Computings, Statistical,Mathematic Computings,Mathematical Computings,Statistical Computings
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D010599 Pharmacokinetics Dynamic and kinetic mechanisms of exogenous chemical DRUG LIBERATION; ABSORPTION; BIOLOGICAL TRANSPORT; TISSUE DISTRIBUTION; BIOTRANSFORMATION; elimination; and DRUG TOXICITY as a function of dosage, and rate of METABOLISM. LADMER, ADME and ADMET are abbreviations for liberation, absorption, distribution, metabolism, elimination, and toxicology. ADME,ADME-Tox,ADMET,Absorption, Distribution, Metabolism, Elimination, and Toxicology,Absorption, Distribution, Metabolism, and Elimination,Drug Kinetics,Kinetics, Drug,LADMER,Liberation, Absorption, Distribution, Metabolism, Elimination, and Response
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D001812 Blood-Brain Barrier Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue. Brain-Blood Barrier,Hemato-Encephalic Barrier,Barrier, Blood-Brain,Barrier, Brain-Blood,Barrier, Hemato-Encephalic,Barriers, Blood-Brain,Barriers, Brain-Blood,Barriers, Hemato-Encephalic,Blood Brain Barrier,Blood-Brain Barriers,Brain Blood Barrier,Brain-Blood Barriers,Hemato Encephalic Barrier,Hemato-Encephalic Barriers
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

T Sakane, and M Nakatsu, and A Yamamoto, and M Hashida, and H Sezaki, and S Yamashita, and T Nadai
June 1988, Journal of pharmaceutical sciences,
T Sakane, and M Nakatsu, and A Yamamoto, and M Hashida, and H Sezaki, and S Yamashita, and T Nadai
February 1989, Pharmaceutical research,
T Sakane, and M Nakatsu, and A Yamamoto, and M Hashida, and H Sezaki, and S Yamashita, and T Nadai
August 1990, Journal of pharmaceutical sciences,
T Sakane, and M Nakatsu, and A Yamamoto, and M Hashida, and H Sezaki, and S Yamashita, and T Nadai
December 1985, Journal of pharmacokinetics and biopharmaceutics,
T Sakane, and M Nakatsu, and A Yamamoto, and M Hashida, and H Sezaki, and S Yamashita, and T Nadai
February 1987, Pharmaceutical research,
T Sakane, and M Nakatsu, and A Yamamoto, and M Hashida, and H Sezaki, and S Yamashita, and T Nadai
June 1994, The Journal of pharmacy and pharmacology,
T Sakane, and M Nakatsu, and A Yamamoto, and M Hashida, and H Sezaki, and S Yamashita, and T Nadai
February 1991, Journal of pharmacokinetics and biopharmaceutics,
T Sakane, and M Nakatsu, and A Yamamoto, and M Hashida, and H Sezaki, and S Yamashita, and T Nadai
January 1977, Biochemical Society transactions,
T Sakane, and M Nakatsu, and A Yamamoto, and M Hashida, and H Sezaki, and S Yamashita, and T Nadai
December 2009, International journal of pharmaceutics,
T Sakane, and M Nakatsu, and A Yamamoto, and M Hashida, and H Sezaki, and S Yamashita, and T Nadai
April 2007, Clinical and experimental pharmacology & physiology,
Copied contents to your clipboard!